Multiscale Process Modelling in Translational Systems Biology of Leishmania major: A Holistic view

• Published in: Scientific reports 2020-01, Vol.10 (1), p.785-785, Article 785
• Main Authors: Chauhan, Nutan, Singh, Shailza
• Format: Article
• Language: English
• Subjects: 13/106; 13/2; 13/31; 13/44; 631/553/2713; 692/699/255/1715; 96/31; 96/63; 96/98; Amastigotes; Animals; Antiprotozoal Agents - chemistry; Antiprotozoal Agents - pharmacology; Apoptosis; Cell Cycle - drug effects; Cell death; Disease Models, Animal; Free radicals; G1 phase; Humanities and Social Sciences; Lactoylglutathione Lyase - antagonists & inhibitors; Lactoylglutathione Lyase - chemistry; Lactoylglutathione Lyase - metabolism; Leishmania major; Leishmania major - drug effects; Leishmania major - enzymology; Leishmania major - growth & development; Leishmaniasis; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular modelling; multidisciplinary; Parasite Load; Parasites; Parasitic diseases; RAW 264.7 Cells; Science; Science (multidisciplinary); Systems Biology; Vector-borne diseases
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-57640-4

Present work aims to utilize systems biology and molecular modelling approach to understand the inhibition kinetics of Leishmania major GLO I and identifying potential hit followed by their validation through in vitro and animal studies. Simulation of GLO I inhibition has shown to affect reaction fluxes of almost all reactions in the model that led to increased production of various AGEs and free radicals. Further, in vitro testing of C1 and C2, selected through molecular modelling revealed remarkable morphological alterations like size reduction, membrane blebbing and loss in motility of the parasite, however, only C1 showed better antileishmanial activity. Additionally, C1 showed apoptosis mediated leishmanicidal activity (apoptosis-like cell death) along with cell-cycle arrest at sub-G0/G1 phase and exhibited potent anti-leishmanial effect against intracellular amastigotes. Furthermore, decrease in parasite load was also observed in C1 treated BALB/c female mice. Our results indicate that C1 has healing effect in infected mice and effectively reduced the parasitic burden. Hence, we suggest C1 as a lead molecule which on further modification, may be used to develop novel therapeutics against Leishmaniasis .